Cure Meds Private Limited
About Cure Meds Private Limited
Data last updated:
Cure Meds Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 09 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2015PTC074952. Its GSTIN is 09AAGCC3241A2Z6 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kareshma Khanna and Seema Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 A Way Road Gokhale Marg, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.45 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹3,744 (net margin 0.1%) and EBITDA of ₹12,096 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cure Meds Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6 A Way Road Gokhale Marg, Lucknow, Uttar Pradesh, India – 226001
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Cure Meds Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cure Meds is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cure Meds Private Limited, buy the company report.
Financials of Cure Meds Private Limited
FY 2025 filings availableCure Meds Private Limited reported revenue of ₹38.45 Lakh (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 5% fall in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12,096 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,744 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cure Meds Private Limited, buy the company report.
Board of directors of Cure Meds Private Limited
Cure Meds has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranav Agarwal | Additional Director | 01 Apr 2020 | 6 Years 6 Months | Current |
| Kareshma Khanna Also directs: Sri Harkrishan Colonisers & Promoters Private Limited | Director | 31 Jul 2018 | 8 Years 2 Months | Current |
| Seema Khanna | Director | 09 Dec 2015 | 10 Years 10 Months | Current |
Peer comparison
Cure Meds Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Santdariyamai Agri Producer Company Limited | ₹38.46 Lakh (FY 2025) | 209.0% | Hingoli, Maharashtra, India | |||
| Ecomfab India Private Limited | ₹38.46 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Aishi Hospitality and Nutrition Private Limited | ₹38.46 Lakh (FY 2018) | -44.0% | Mumbai, Maharashtra, India | |||
| Jalaram Impex Private Limited | ₹38.45 Lakh (FY 2025) | -88.0% | Surat, Gujarat, India | |||
| Softwill Health Private Limited | ₹38.45 Lakh (FY 2024) | Kadi, Gujarat, India | ||||
| Cure Meds Private Limitedthis company | ₹38.45 Lakh (FY 2025) | ₹3,744 | 0.1% | -5.0% | Lucknow, Uttar Pradesh, India | |
| Mahishi Multi Farmers Producer Company Limited | ₹38.45 Lakh (FY 2019) | Imphal, Manipur, India | ||||
| Spectec Surgical Private Limited | ₹38.45 Lakh (FY 2025) | 79.0% | Ring Road Naraina, Delhi, India | |||
| Kashyap Pharmaceuticals Private Limited | ₹38.44 Lakh (FY 2024) | 86.0% | Thane, Maharashtra, India | |||
| Mayrav Buildtrade Private Limited | ₹38.44 Lakh (FY 2021) | 165.0% | Ahmedabad, Gujarat, India | |||
| Refit Actiwear India Private Limited | ₹38.44 Lakh (FY 2025) | -16.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Cure Meds Private Limited, buy the company report.
Auditor
Cure Meds Private Limited is audited by SETH & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SETH & ASSOCIATES | FY 2022 | 001167C |
Shareholding
The shareholding of Cure Meds Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cure Meds Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cure Meds Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cure Meds Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cure Meds has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCC3241A2Z6 | Uttar Pradesh | Active | 25 Oct 2017 |
To see the full GST registrations and return filing status of Cure Meds Private Limited, buy the company report.
Recent activity
Cure Meds Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Pranav Agarwal was appointed as Additional Director on 01 Apr 2020.
Frequently asked questions
Cure Meds is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 09 December 2015 (11+ years old) and is registered under CIN U24233UP2015PTC074952.
Cure Meds has 3 current directors:
- Pranav Agarwal - Additional Director
- Kareshma Khanna - Director
- Seema Khanna - Director
The latest financial statements of Cure Meds on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Cure Meds is 09AAGCC3241A2Z6, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Cure Meds is U24233UP2015PTC074952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cure Meds was incorporated on 09 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Cure Meds by revenue are Santdariyamai Agri Producer Company Limited, Ecomfab India Private Limited, Aishi Hospitality and Nutrition Private Limited, Jalaram Impex Private Limited, Softwill Health Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Pranav Agarwal was appointed as Additional Director on 01 Apr 2020. Sanjive Khanna ceased to be Director on 30 Mar 2019. Kareshma Khanna was appointed as Director on 31 Jul 2018. Cure Meds has 4 board changes on record in total.
The registered office of Cure Meds is at 6 A Way Road Gokhale Marg, Lucknow, Uttar Pradesh, India – 226001.
Cure Meds operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Cure Meds is compliant as of 05 September 2026. The company is actively filing with the Registrar of Companies.